$21.8 million for neurological disorders research
25 June 2020 The Morrison Government is investing $21.8 million in vital research that could mean major breakthroughs in treating a range of neurological disorders, including early Alzheimer’s disease, autism and encephalitis. This research could change lives. It…
Australians Among First In The World To Open Access For Life-Saving Minimally Invasive Heart Treatment To All Patients
25 June 2020 All Australians living with symptoms of severe aortic stenosis no longer face open heart surgery as the only treatment option, with public access to a less invasive therapy – previously reserved for only the sickest…
Planet Innovation produces beta units of Truvian’s automated point-of-care blood testing system
24 June 2020 Planet Innovation (PI), a healthtech innovation and commercialization company, has partnered with Truvian, a healthcare company at the intersection of diagnostics and consumer technology, to design and manufacture a new point-of-care blood testing device to…
New light shone on inflammatory cell death regulator
19 June 2020 Walter and Eliza Hall Institute researchers have made significant advances in understanding the inflammatory cell death regulatory protein MLKL and its role in disease. In a trio of studies published today in the journal Nature Communications,…
Appointment of Jeff Malone as BioMelbourne Network Chief Executive Officer
Announcement Date: 17 June 2020 The Board of Directors of BioMelbourne Network is delighted to announce the appointment of Jeff Malone as Chief Executive Officer, effective 13th July 2020. Jeff holds a Bachelor of Electrical Engineering from…
Dr Larry Marshall reappointed as CSIRO Chief Executive
22 June 2020 The Board of Directors of CSIRO, Australia’s national science agency, is pleased to reappoint Dr Larry Marshall as Chief Executive for a further three years. Dr Marshall joined CSIRO in 2015. David Thodey AO, Chair…
Grey Innovation: NOTUS Ventilator Program Update
22 June 2020 Ten weeks ago, the Hon Karen Andrews MP, Minister for Industry, Science and Technology announced the $31.3m Grey Innovation supply contract for 2,000 emergency invasive ventilators. Named after the Greek God of Southern Wind, the…
Burnet vaccine modelling shaping global policies for hepatitis B elimination
18 June 2020 Cost-effective ways to improve the delivery and management of hepatitis B (HBV) vaccine, identified in new Burnet Institute research, have attracted interest from global policymakers including the World Health Organization (WHO) and Gavi, the international vaccine alliance. The…
Medtronic and Foxconn Partner to Increase Ventilator Production
18 June 2020 Companies Aim to Produce 10,000 Puritan Bennett™ 560 Ventilators Together in the United States Over the Next Year Partnership Established after Medtronic Announces Ventilator Open Source Initiative Medtronic plc (NYSE:MDT) and Foxconn Industrial Internet, a…
Chasing COVID-19: CSIRO scientists find fast, cheaper way to find outbreaks in our wastewater
19 June 2020 Tracking community outbreaks of COVID-19 through wastewater can happen faster, using more cost-effective tests, according to new research published by the Australian national science agency, CSIRO. The new research builds on the world’s first peer-reviewed…
Noxopharm COVID-19 Trial Program to Commence in Europe
19 June 2020 NOX proceeding with its COVID-19 clinical program in Europe while discussions with FDA continue Phase 1 trial aiming to confirm proof-of-principle and safety of Veyonda® in a timely and cost-effective way before committing to a…
Cynata Announces Ethics Approval and Expedited Regulatory Pathway for Phase 3 Osteoarthritis Clinical Trial
18 June 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to report important progress towards the commencement of recruitment in the Phase 3 clinical trial of CYP-004, its CymerusTM mesenchymal stem cell…
